{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-008509","form_type":"8-K","ticker":"ISCO","cik":"0001355790","company_name":"International Stem Cell CORP","filed_at":"2022-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.094291+00:00","generated_at":"2026-06-27T01:54:50.979380+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"International Stem Cell extends $2.9M CEO loan maturity to Sept 15, 2022","bullets":["Extended maturity of $2.9M promissory note from CEO Andrey Semechkin to Sept 15, 2022 (was Mar 15, 2022).","Note is unsecured, non-convertible, bears 4.5% annual interest.","Loan originated Jan 13, 2022; this new note replaces the original on same principal.","CEO Semechkin is Co-Chairman and CEO; transaction is a related-party financing.","Company may prepay the note at any time without penalty."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-008509","json":"https://secwatch.observer/filing/0001564590-22-008509.json","markdown":"https://secwatch.observer/filing/0001564590-22-008509.md","text":"https://secwatch.observer/filing/0001564590-22-008509.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1355790/000156459022008509/0001564590-22-008509-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1355790/000156459022008509/isco-8k_20220301.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T01:54:50.979380+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}